Private Equity Adjusts Research Priorities in March, Anticipating 'Plentiful Prospects' in Sci-Tech Innovation
1 day ago / Read about 0 minute
Author:小编   

In March, private equity entities recalibrated their research focal points, with 871 such firms engaging in more than 2,700 research sessions concerning A-shares. The electronics sector emerged as the primary area of interest, trailed closely by the pharmaceutical and biological industries. Notably, private equity firms with assets under management in the billion-dollar range also displayed a preference for the electronics and pharmaceutical sectors. Industry experts opine that amid escalating geopolitical tensions, targets associated with technological innovation stand out as a premier option for maneuvering through market uncertainties.